Increased SSTR2A and SSTR3 expression in succinate dehydrogenase–deficient pheochromocytomas and paragangliomas
- 1 March 2015
- journal article
- research article
- Published by Elsevier BV in Human Pathology
- Vol. 46 (3), 390-396
- https://doi.org/10.1016/j.humpath.2014.11.012
Abstract
No abstract availableKeywords
Funding Information
- Waikato Medical Research Foundation (188)
- Waikato Medical Research Foundation (188)
- Cancer Institute NSW (188)
This publication has 34 references indexed in Scilit:
- Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma inSDHxMutation Carriers: A Multicenter Prospective Study from the PGL.EVA InvestigatorsJournal of Clinical Endocrinology & Metabolism, 2013
- Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor TargetingThe American Journal of Surgical Pathology, 2012
- Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomasEndocrine-Related Cancer, 2011
- Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormonesecreting adrenal phaeochromocytoma: review of the literature and report of a caseEuropean Journal of Histochemistry, 2009
- Differential Expression of the Human Somatostatin Receptor Subtypes sst1 to sst5 in Various Adrenal Tumors and Normal Adrenal GlandHormone and Metabolic Research, 2005
- Are Somatostatin Analogs Therapeutic Alternatives in the Management of Head and Neck Paragangliomas?The Laryngoscope, 2005
- AnIn VivoOctreoScan-Negative Adrenal Pheochromocytoma Expresses Somatostatin Receptors and Responds to Somatostatin Analogs TreatmentIn VitroHormone and Metabolic Research, 2003
- Effects of slow‐release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytomaClinical Endocrinology, 2002
- Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytomaClinical Endocrinology, 1997
- Beneficial effects of octreotide in a patient with a metastatic paragangliomaEuropean Journal Of Cancer, 1996